HIMSS TV

Based on learnings from a HIMSS CIO Connect session, Lateefah Agunbiade of Roanoke Chowan Community Health Center was able to collaborate with her organization's CFO to gain support for a digital modernization initiative.

The health equity component of value-based care always had a primary and preventive care focus. There is movement to include specialists in that dialogue particularly within an aging population, says HSBlox operations chief Lynn Carroll.

Using 400 logic "languages," Dr. R. Ryan Sadeghian, pediatrician and University of Toledo CMIO, and his team are building pediatric-specific AI apps that deliver safe, context-aware responses to support pediatric diagnoses.

In 2025, providers will face an uncertain global economy, shrinking reimbursements, impacts of inflation, rising operational costs, more expensive labor and supply costs and administrative overhead costs, says AdvancedMD CEO Amanda Sharp.

Michele Krajewski, HIMSS' Global Health Conference Education Committee chair, explains how the committee ensures each year's conference curriculum reflects the interests and needs of HIMSS' diverse membership.

Unlearn leverages digital twin models to simulate how participants may respond to treatments, according to CEO Steve Herne. This approach streamlines clinical trials by enhancing data precision and improving the quality of outcomes.

Banner Health's "Text the CEO" initiative allowing patients and families to give leaders their feedback in real time has helped improve patient satisfaction, according to senior digital product manager Amy Adashek-Pinn.

The updates are a refresh to put more onus around payers/providers to mature their cybersecurity program, says Ferdinand Hamada, managing director of the healthcare, pharma and life sciences sector at MorganFranklin Cyber.

Ran Balicer, chief innovation officer at Clalit Health Services, believes AI implementation is necessary to advance healthcare and recommends that organizations create guardrails to ensure safe, ethical AI deployment.

Amprion CEO Russ Lebovitz says proteins in the brain can misfold and form particles that spread from cell to cell, triggering neurodegenerative diseases. A test can identify these proteins, allowing for early diagnosis before symptoms appear.